Updated: March 11, 2026
Praluent Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

- Common Side Effects of Praluent (Over 5% of Patients)
- For Patients with High Cholesterol (Primary Hyperlipidemia):
- For Patients with Established Cardiovascular Disease:
- Less Common but Reported Side Effects
- Serious Side Effects: When to Seek Immediate Medical Attention
- What Praluent Does NOT Cause
- Tips for Managing Injection Site Reactions
- Pregnancy and Breastfeeding
Overview
Praluent (alirocumab) has a good safety profile, but side effects do occur. Learn what's common, what's serious, and when you should contact your doctor.
Is Praluent in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Praluent near you.
Praluent (alirocumab) has an overall favorable safety profile — it doesn't have a boxed warning, it doesn't damage the liver, and it doesn't cause the muscle pain (myopathy) that statins sometimes do. But like any medication, it can cause side effects, and a few of them require prompt medical attention. Here's what you need to know.
Common Side Effects of Praluent (Over 5% of Patients)
In clinical trials, the most common side effects seen in more than 5% of Praluent patients (and more frequently than placebo) were:
Check live stock now.
For Patients with High Cholesterol (Primary Hyperlipidemia):
Injection site reactions: Redness, pain, swelling, bruising, or itching at the injection site. Usually mild and resolve on their own.
Influenza (flu): Flu and flu-like symptoms including fever, body aches, and fatigue. Also includes nasopharyngitis (cold-like symptoms such as runny nose, sore throat, sneezing).
For Patients with Established Cardiovascular Disease:
Myalgia (muscle pain): Muscle pain or aches, reported more frequently in cardiovascular disease patients. Note: unlike statins, Praluent does not appear to cause true drug-induced myopathy.
Less Common but Reported Side Effects
Diarrhea
Urinary tract infection
Bruising at injection sites
Mild skin rash, itching, or hives (usually not serious, but monitor for escalation)
Serious Side Effects: When to Seek Immediate Medical Attention
Praluent can cause serious allergic reactions that require prompt medical attention. Stop using Praluent and seek emergency care immediately if you experience any of the following:
Angioedema: Swelling of the face, lips, tongue, or throat — can be life-threatening if it impairs breathing
Hypersensitivity vasculitis: Inflammation of blood vessels — a rare but serious allergic reaction reported with Praluent use
Severe skin reactions: Severe rash, widespread hives, or skin redness
Difficulty breathing or swallowing
These serious hypersensitivity reactions have been reported with Praluent use and have required hospitalization in some cases. Praluent is contraindicated in anyone with a history of a serious allergic reaction to alirocumab or any of its ingredients.
What Praluent Does NOT Cause
There are some common concerns about cholesterol medications that specifically do NOT apply to Praluent:
No liver toxicity: Unlike some older cholesterol drugs, Praluent does not require routine liver enzyme monitoring
No significant statin-type myopathy: The ODYSSEY trials found no significant difference in muscle-related adverse events between Praluent and placebo
No boxed warning (Black Box Warning): Praluent does not carry a boxed warning from the FDA
No known significant drug-drug interactions: Unlike many medications, alirocumab is degraded to small peptides and amino acids and doesn't interact with common drugs like statins, blood pressure medications, or anticoagulants
Found
Rate
on average
Tips for Managing Injection Site Reactions
Injection site reactions are the most commonly reported side effect of Praluent. To minimize them:
Allow the pen to reach room temperature for 30–40 minutes before injecting — cold injections are more uncomfortable
Rotate injection sites — use the thigh, abdomen, or upper arm, alternating locations each time
Avoid injecting into areas that are bruised, red, tender, or hardened
Apply a cold compress before injection if you find it helps reduce discomfort
Pregnancy and Breastfeeding
The safety of Praluent during pregnancy is unknown. If you become pregnant while taking Praluent, contact your healthcare provider immediately and report the pregnancy to Regeneron at 1-844-734-6643. The decision to continue Praluent while breastfeeding should be made with your doctor, as it is unknown whether alirocumab passes into breast milk in significant amounts.
For information about drug interactions with Praluent, see our guide: Praluent Drug Interactions: What to Avoid and What to Tell Your Doctor.
Frequently Asked Questions
Generally no. Unlike statins, Praluent (alirocumab) is not associated with drug-induced myopathy. However, some patients — particularly those with established cardiovascular disease — do report myalgia (muscle pain) as a side effect. The ODYSSEY clinical trials did not find a significant difference in serious muscle-related adverse events between Praluent and placebo.
Injection site reactions (redness, pain, swelling, or itching) are among the most common side effects of Praluent, reported in more than 5% of patients. They are usually mild and resolve on their own. Allowing the pen to warm to room temperature for 30–40 minutes before injecting and rotating injection sites can reduce their frequency and severity.
Yes, though rarely. Serious hypersensitivity reactions including angioedema (swelling of the face, lips, tongue, or throat) and hypersensitivity vasculitis have been reported with Praluent and have required hospitalization. Stop using Praluent and seek emergency medical care immediately if you experience severe swelling, difficulty breathing, or a serious rash.
No. Praluent (alirocumab) does not carry an FDA boxed warning (Black Box Warning). Its most significant safety concern is hypersensitivity reactions, which are addressed in the Warnings and Precautions section of the prescribing information.
Praluent works through a completely different mechanism than statins and is not associated with the same type of muscle toxicity. Many patients who cannot tolerate statins due to muscle pain take PCSK9 inhibitors like Praluent successfully. Always discuss your medication history with your doctor before starting Praluent.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Praluent also looked for:
More about Praluent
39,483 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





